November 14, 2017 — Fujifilm Medical Systems U.S.A. Inc. announced that its FDR AQRO and FDR D-EVO GL Panel have received 2017 Innovative Technology designations from Vizient Inc., the largest member-driven healthcare performance improvement company in the country. The designations were based on direct feedback from hospital clinicians who interacted with the FDR AQRO and FDR D-EVO GL Panel at the Vizient Innovative Technology Exchange in Denver on Sept. 14, 2017.
The FDR AQRO is a mini point-of-care digital X-ray system that combines a high-performing and unique infection control design with the sensitivity of Fujifilm's FDR D-EVO II detectors and latest highly refined image processing advancements to generate high-resolution images with low patient dose.
The FDR D-EVO GL panel is the world’s first single exposure long-length detector, according to the company. FDR D-EVO GL enhances the workflow of long-view radiography by capturing the entire image in a single exposure in just a few seconds, reducing the chance for patient motion-induced artifacts and time for the patient to remain still. This new digital radiography (DR) imaging is further complemented with the ability to capture its images without a grid utilizing Virtual Grid simulation software, lowering dose up to 50 percent compared to grid exams.
Vizient represents a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute healthcare providers, and represents more than $100 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to review potentially innovative products. If it is determined that a product is innovative, Vizient may award a contract outside of the competitive bid cycle.
For more information: www.fujimed.com
July 18, 2024 
